ULTRASOUND IMAGING OF THE TERMINAL THORACIC DUCT IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION

Hùng Khởi Trịnh , Ngọc Cương Nguyễn

Main Article Content

Abstract

Objective: Describe the characteristics of the termninal thoracic duct (TTD) in patients with cirrhosis - portal hypertension by ultrasound and evaluate the correlation between the degree of dilatation of the TTD with some manifestations of cirrhosis. Materials and Methods: Cross-sectional descriptive study, 30 patients were diagnosed and treated for cirrhosis at Hanoi Medical University Hospital from December 2023 to July 2024. Results: 30 cirrhosis patients (27 men: 3 women; mean age 60,3 ± 9,7 years); 08 Child Pugh A patients (26,7%), 16 Child Pugh B patients (53,3%), and 06 Child Pugh C patients (20%) with mean diameter TTD is 3,89 ± 0,94mm. The average level of esophageal varices is grade II. The dilation of portal veins occurs in 16 patients (53,3%) with the average diameter of the portal vein is 12,7±3mm by sonography. Ascites occurs in 21 patients (70%) and mainly in group 2 (66,67%). TTD  is dilated in the range of 3 to <5mm (group 2) accounts for a higher rate (77,4%) than group 3 (16,1%) and group 1 (6,4%). The degree of dilatation of TTD is closely correlated with the degree of cirrhosis (r = 0,54; p = 0,02 < 0,05) and the degree of portal hypertension - assessed indirectly by ascites (r =0,39; p=0,03), portal varix (r=0,37; p=0,04) and esophageal varices with (r=0,39; p=0,03). Conclusions: Diameter of TTD increases in patients with cirrhosis and correlates with the severity of cirrhosis and portal hypertension

Article Details

References

Riley LE, Ataya A. Clinical approach and review of causes of a chylothorax. Respir Med. 2019; 157:7-13. doi:10.1016/j.rmed.2019.08.014
2. Cuong NN, Linh LT, My TTT, et al. Management of chyluria using percutaneous thoracic duct stenting. CVIR Endovasc. 2022;5:54. doi:10.1186/s42155-022-00333-y
3. Guevara C, Rialon K, Ramaswamy R, Kim S, Darcy M. US–Guided, Direct Puncture Retrograde Thoracic Duct Access, Lymphangiography, and Embolization: Feasibility and Efficacy. J Vasc Interv Radiol. 2016;27. doi:10.1016/ j.jvir.2016. 06.030
4. Dumont AE, Mulholland JH. Alterations in Thoracic Duct Lymph Flow in Hepatic Cirrhosis: Significance in Portal Hypertension. Ann Surg. 1962;156(4): 668-675. doi:10.1097/00000658-196210000-00013
5. Witte MH, Dumont AE, Cole WR, Witte CL, Kintner K. Lymph circulation in hepatic cirrhosis: effect of portacaval shunt. Ann Intern Med. 1969; 70(2):303-310. doi:10.7326/0003-4819-70-2-303
6. Witte MH, Witte CL, Dumont AE. Progress in liver disease: physiological factors involved in the causation of cirrhotic ascites. Gastroenterology. 1971;61(5):742-750.
7. Seeger M, Bewig B, Günther R, et al. Terminal Part of Thoracic Duct: High-Resolution US Imaging. Radiology. 2009;252(3):897-904. doi:10.1148/radiol.2531082036
8. Child-Pugh classification - UpToDate. Accessed June 18, 2024. https://www.uptodate. com/contents/image?imageKey=GAST/78401
9. Verma SK, Mitchell DG, Bergin D, et al. Dilated cisternae chyli: a sign of uncompensated cirrhosis at MR imaging. Abdom Imaging. 2009; 34(2): 211-216. doi:10.1007/s00261-008-9369-7
10. Hwang SH, Oh YW, Ham SY, Kang EY, Lee KY, Yong HS. Evaluation of the left neck distal thoracic duct in cirrhosis with computed tomography. Clin Imaging. 2016;40(3):465-469. doi:10.1016/j.clinimag.2016.01.005